The immunogenicity and efficacy of the recently approved 9-valent human papillomavirus vaccine were similar to that of the currently approved and reco... More »
The immunogenicity and efficacy of the recently approved 9-valent human papillomavirus vaccine were similar to that of the currently approved and reco... More »
Immunity against the hepatitis C virus can be induced by cultured primary human liver sinusoidal endothelial cells, according to a study published in ... More »
Specific clinical features present in patients with inflammatory bowel disease can significantly increase their risks for developing cytomegalovirus (CMV) disease, according to a study published in...
SAN FRANCISCO – Autologous hematopoietic stem cell transplantation should be offered to patients with HIV-related lymphomas and treatment-responsive HIV infection, results from a new study...
Patients who are to undergo immunosuppressive therapy but are at high risk for reactivation of hepatitis B infection should receive antiviral prophylaxis, rather than being monitored for reactivation...
AUSTIN, TEX. – Use of acid-suppressing drugs was associated with more severe presentation, longer hospital stay, and increased mortality among patients with community-acquired pneumonia presenting to...
Sofosbuvir plus GS-5816 appears to be a promising treatment regimen for treatment-naive patients with chronic genotype 1-6 hepatitis C virus infection without cirrhosis, according to a new study....
BOSTON – Treating recurrent hepatitis C infection after liver transplantation using sofosbuvir-containing regimens produced a sustained virologic response 4 weeks later in 60%-90% of 237 patients,...
BOSTON – All but 1 of 51 patients who failed sofosbuvir-containing treatment regimens for hepatitis C achieved a sustained virologic response for 12 weeks after retreatment with ledipasvir and...